Skip to main content
Equibles

BARCLAYS PLC

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,049,989
-$126,927 QoQ
Shares Held
117,844
-13.6% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. KYTX ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,049,989 117,844
2026-03-31 $1,176,916 136,375
2025-12-31 $1,547,878 164,668
2025-09-30 $457,146 76,191
2025-06-30 $154,708 50,394
2025-03-31 $157,082 81,390
2024-12-31 $335,051 89,586
2024-09-30 $343,116 70,167
2024-06-30 $433,117 57,749
2024-03-31 $1,070,454 43,094